Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
04/03/2023 | Century Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 7.5k | $1.03 | $7.7k | | 04/03/2023 |
03/23/2023 | Century Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 220.9k | $1.03 | $227.6k | | 03/21/2023 |
03/23/2023 | Century Therapeutics, Inc. | | Sale | Common Stock | 15.6k | $3.55 | $55.4k | | 03/21/2023 |
03/22/2023 | Century Therapeutics, Inc. | | Sale | Common Stock | 65.7k | $3.72 | $244.6k | | 03/21/2023 |
03/22/2023 | Century Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 65.7k | $1.03 | $67.7k | | 03/21/2023 |
03/21/2023 | Century Therapeutics, Inc. | | Exercise | Stock Option (right to buy) | 63.6k | $1.03 | $65.5k | | 03/21/2023 |
03/21/2023 | Century Therapeutics, Inc. | | Sale | Common Stock | 63.6k | $3.77 | $239.9k | | 03/21/2023 |
02/02/2023 | Century Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 131.2k | $4.64 | $609k | | 02/02/2023 |
02/02/2023 | Century Therapeutics, Inc. | | Grant | | 21.9k | $0.00 | $0 | | 02/02/2023 |
01/25/2022 | Century Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 105k | $13.15 | $1.4M | | 01/25/2022 |
01/03/2017 | FIVE PRIME THERAPEUTICS, INC. | FPRX | Payment of Exercise | Common Stock | 1.3k | $48.60 | $63.5k | | 01/03/2017 |